Back to Stenocare® or All Oil Concentrates

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This product was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Dosing Look-Up Table (Estimated)

0.01/g3/mg THC0.1/mg CBD
0.05/g15/mg THC0.5/mg CBD
0.1/g30/mg THC1/mg CBD
0.15/g45/mg THC1.5/mg CBD
0.2/g60/mg THC2/mg CBD
0.25/g75/mg THC2.5/mg CBD
0.3/g90/mg THC3/mg CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
Denmark Stenocare®
Designation
THC T30:C1
Chemotype
Type I: High THC
Carrier Oil
Olive Oil
THC Potential Range (±10%)
27-33/mg
CBD Potential Range (±10%)
0.9-1.1/mg
Cultivated in
Flag of Denmark Denmark
Imported by
United Kingdom Curaleaf Laboratories
Imported as
Schedule II: Finished Product
Formulated in
Flag of Denmark Denmark

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Available

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Main Partner Pharmacy

Pharmacy Distributor

Dispensing Patient Pharmacies

Product DescriptionPatient Reviews

Denmark About Stenocare A/S

Stenocare® Logo

Denmark's leading pharmaceutical supplier of medical cannabis. Stenocare is a publicly-traded Danish company that supplies prescription-based medical cannabis oils to patients in the Northern European and Australian market.

Stenocare grows, imports and distributes prescription-based medical cannabis oils.

Today, Stenocare operates in Denmark, Sweden, Norway, UK and Australia with 11 different prescription-based medical cannabis oil products for the treatment of pain and a variety of other conditions.

Stenocare works to ensure that doctors and patients can access a well-documented and pharmaceutical quality range of cannabis products. Stenocare operates in multiple countries, with a strong focus on providing prescription-based medical cannabis oils to patients.

Stenocare was the first Danish company to succeed in introducing prescription-based medical cannabis oil to Denmark, Sweden and Norway. The pharmaceutical products are monitored by the medicines agencies. Stenocare currently operates in Denmark, Sweden, Norway, UK and Australia and expects to have access to new markets in the coming years to enable more patients acquiring prescription-based medical cannabis.

Stenocare has received three permits from the Danish Medicines Agency to grow, handle and trade in narcotic substances as well as import and distribute medical cannabis in Denmark.

The Danish Medicines Agency controls and inspects companies that produce medicines – both before and after introduction to the market. The Danish Medicines Agency also controls companies that sell medicines. Only companies that have received written permission from the Danish Medicines Agency may produce and sell medicines in Denmark.

stenocare.com

  Information provided is partially -sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)